Skip to main content
Premium Trial:

Request an Annual Quote

NeoClone Nabs $750K SBIR Grant to Continue Developing Ovarian Cancer Antibody Array

NEW YORK (GenomeWeb News) — NeoClone Biotechnology has received a $750,000 Phase II Small Business Innovation Research grant from the National Institutes of Health to help it continue developing an antibody microarray for ovarian cancer, the company said this week.
The funding, administered through the National Cancer Institute, will pay for continued research and new equipment and staff for its Madison, Wis., labs.
NeoClone said the antibody array will use its proprietary method for generating monoclonal antibodies to certain ovarian cancer-related targets.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.